Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study

Table 1 Multivariable Cox regression of target interventions for COVID-19

Intervention	Adjusted HR^a	95% CI	pvalue^b
Atorvastatin	0.38	0.18–0.77	0.008
Steroids	1.93	0.81–4.59	0.136
Hydroxychloroquine	0.81	0.31–2.10	0.675
Colchicine	0.41	0.17–0.98	0.045
Tocilizumab	1.17	0.42–3.25	0.765
Azithromycin	0.49	0.20–1.23	0.132

Abbreviations: CI confidence interval, COVID-19 coronavirus disease 2019, HR hazard ratio
^aAdjusted for age, number of comorbidities, hypertension, cardiovascular disease, severity, invasive mechanical ventilation, and antibiotics other than azithromycin
^bp < 0.05 was considered statistically significant

ISSN: 1364-8535